Medical and Scientific Writing Services for Biotech and Pharma
Regulatory submissions, clinical study reports, and scientific communications for early-stage biotech and established pharma companies. Every document is produced by a team with genuine regulatory and pharmaceutical background: one that understands what the document needs to accomplish before a word is written.
Regulatory Writing
IND, NDA, and BLA applications; CMC sections; clinical study reports; investigator brochures; protocol writing; eCTD-formatted submission documents. Written with a clear understanding of what each reviewing body expects in each module, and structured to minimize information requests.
Document types we write:
· Investigational New Drug (IND) applications
· New Drug Applications (NDA) and Biologics License Applications (BLA)
· Chemistry, Manufacturing, and Controls (CMC) sections
· Clinical Study Reports (CSR)
· Investigator Brochures (IB)
· Clinical trial protocols
· eCTD-formatted submission packages
· Informed consent forms
Scientific Communications
Scientific platform development, white papers, congress presentations, and peer-reviewed materials. We translate complex mechanisms and trial outcomes into precise, well-structured content for scientific and clinical audiences who need to evaluate the data, not just receive a summary.
Engagements include:
· Scientific narrative and platform development
· White papers and in-house publications
· Congress and conference presentation materials
· Peer-reviewed content support
· Scientific content for non-scientific audiences
Clinical Evidence Communication
Trial data and global evidence reframed as accessible narratives for healthcare providers, investors, and regulators. Each audience requires a different level of technical detail and a different entry point into the data. We develop clinical evidence communications that work at each level without sacrificing accuracy at any of them.
Engagements include:
· HCP-facing clinical evidence materials
· Evidence summaries for regulatory and payer audiences
· Data visualization and storytelling support
· Outcomes communication
Investor and Partnership Materials
Pitch decks, data narratives, and partnership communications that carry scientific credibility. We help companies present their pipeline to investors and potential partners who evaluate dozens of programs, ensuring the nuance that makes your program distinct is preserved and communicated, not smoothed over.
Engagements include:
· Scientific pitch deck development
· Pipeline and portfolio narratives
· Partnership and licensing communications
· Due diligence support materials
Why Scientific Background Changes the Work
Most technical writers understand how to format a regulatory document. Fewer understand what an FDA reviewer expects in a specific module, why a CSR structured a certain way generates a Complete Response Letter, or how to describe mechanism of action in four different registers for four different audiences without losing accuracy in any of them.
Our team carries that background. It shapes how we approach every document: not as a writing exercise, but as a communication problem with a specific audience, a specific regulatory context, and a specific standard of accuracy the work has to meet.
We function as an integrated extension of our clients' teams. That means direct access to the people doing the work, transparent project management, and a final product that reflects your science accurately.